BDBM583465 4-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]heptane-2-carbonyl]-7- methoxy-1-methyl-1H-1,3-benzodiazol- 2-yl}-1-(cyclopropylmethyl)-1H-indol-6- yl)-3-fluorobenzamide::US11524959, Compound 357.

SMILES COc1cc(cc2nc(-c3cc4ccc(cc4n3CC3CC3)-c3ccc(cc3F)C(N)=O)n(C)c12)C(=O)N1CC2CCC1[C@@H]2N

InChI Key

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 583465   

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM583465(US11524959, Compound 357. | 4-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
Go to US Patent